登录查看更多内容

To All NLA Scientific Session Attendees:The "Dialogues from the Dais:CVD Risk Reduction in the Hypertriglyceridemic Patient" is available on-demand

John Nelson MD,FACC,FNLA,FASNC

Director at California Cardiovascular Institute

发布日期: 2020年12月16日

This must-see ,now on-demand CME/CE activity was held on the opening night of the NLA 2020 Virtual Scientific Session,Wednesday,December 2nd,2020.

If you are not a member ....Join at www.Lipid.org!!!

This is an absolutely ,amazing and unique multidisciplinary organization.Our diversity,inclusiveness and equality is wonderful!!!

Our mission is to enhance the practice of lipid management in clinical medicine

Our educational opportunities are wonderful

Welcome aboard!! JR Nelson MD,Founding member and Past President of the Pacific Chapter of the NLA

Alan Brown MD MHA FACC FAHA FASPC MNLA

4 年

Thanks so much, JR for your support!

3 次回应

查看更多评论

要查看或添加评论，请登录

John Nelson MD,FACC,FNLA,FASNC的更多文章

Real-World Characteristics of US Patients Taking Icosapent Ethyl-Suggests We Need To Do Better and Bridge this Gap in Reducing Residual CV Risk !!!

2025年3月15日

Real-World Characteristics of US Patients Taking Icosapent Ethyl-Suggests We Need To Do Better and Bridge this Gap in Reducing Residual CV Risk !!!

Just published in Frontiers in Cardiovascular Medicine -Published 14 March 2025-OPEN ACCESS. Icosapent ethyl(IPE) is…

6 条评论
This is Why in High Risk/Very High Risk Patients-EVEN with an LDL-C<55mg/dl with Triglycerides>/= 150mg/dl -You are NOT DONE REDUCING CVD RISK !!!

2025年3月1日

This is Why in High Risk/Very High Risk Patients-EVEN with an LDL-C<55mg/dl with Triglycerides>/= 150mg/dl -You are NOT DONE REDUCING CVD RISK !!!

This is from the tremendous ,just published "Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density…

14 条评论
Comparison of Product Label vs Real-World Safety Data from Branded Icosapent Ethyl Users:ASelect Analysis Utilizing Market Scan Data

2025年2月23日

Comparison of Product Label vs Real-World Safety Data from Branded Icosapent Ethyl Users:ASelect Analysis Utilizing Market Scan Data

I am pleased and honored to present our just published, Open Access, manuscript which looked at the frequency of atrial…

2 条评论
Atherogenic index of plasma and coronary artery disease:a systemic review and meta-analysis of observational studies

2025年1月25日

Atherogenic index of plasma and coronary artery disease:a systemic review and meta-analysis of observational studies

Wonderful and highly clinically applicable , First Systemic Review and Meta-analysis to Thoroughly Summarize the…

3 条评论
First Systemic Review To Evaluate the Effect of EPA in Recent ACS Patients !!!

2024年12月14日

First Systemic Review To Evaluate the Effect of EPA in Recent ACS Patients !!!

Just published in Cardiology Plus-Open Access.Very important study to show that adding EPA to statins after recent ACS…

8 条评论
"Eicosapentaenoic Acid Induces Anti-inflammatory transcriptomic landscape in T cells implicating a Pathway Independent of Triglyceride Lowering in ..

2024年12月1日

"Eicosapentaenoic Acid Induces Anti-inflammatory transcriptomic landscape in T cells implicating a Pathway Independent of Triglyceride Lowering in ..

Tremendous article by Nathalie A. Reilly et al.

4 条评论
Congratulations to Dr. Richard Oravec for starting the Sports Medicine Residency Program-St.Agnes Medical Center Fresno, California

2024年9月24日

Congratulations to Dr. Richard Oravec for starting the Sports Medicine Residency Program-St.Agnes Medical Center Fresno, California

This is the only Sports Medicine Residency Program in the entire Central Valley of California The diversity of…
When looking at published CVOT's only Prescription Icosapent Ethyl added to Statin Therapy has been shown to Reduce Cardiovascular Mortality

2024年4月14日

When looking at published CVOT's only Prescription Icosapent Ethyl added to Statin Therapy has been shown to Reduce Cardiovascular Mortality

Cardiovascular death maybe a more patient-centric endpoint than a composite CV endpoint that encompasses CV-related…
Undertreatment of Elevated Triglycerides(Tg) in Patients with CVD-Saw a Patient this week with CAD/Carotid disease with LDL-C 44mg/dl and Tg 230mg/dl

2024年2月15日

Undertreatment of Elevated Triglycerides(Tg) in Patients with CVD-Saw a Patient this week with CAD/Carotid disease with LDL-C 44mg/dl and Tg 230mg/dl

The patient is only on Rosuvastatin 20mg/day !!! I immediately started the patient on prescription EPA-icosapent…

4 条评论
I will be giving a Triglyceride Lecture at the 2024 Heart and Lung Institute Symposium on Saturday February 10th ,2024

2024年2月6日

I will be giving a Triglyceride Lecture at the 2024 Heart and Lung Institute Symposium on Saturday February 10th ,2024

Very excited to be invited to give the lecture on Triglycerides.I will be reviewing omega-3 data.

4 条评论

See all articles

To All NLA Scientific Session Attendees:The "Dialogues from the Dais:CVD Risk Reduction in the Hypertriglyceridemic Patient" is available on-demand

John Nelson MD,FACC,FNLA,FASNC

Director at California Cardiovascular Institute

John Nelson MD,FACC,FNLA,FASNC的更多文章

社区洞察

其他会员也浏览了

Interview with CTP2016 Keynote Speaker, Dr. Greg Koski, CEO of ACRES

ITM Antwerp Annual Report 2017

CIOMS released today a "Glossary of ICH terms and definitions"

Dr. Paul Davis selected as Top Endocrine Pharmacologist of the Year by the International Association of Top Professionals (IAOTP)

Early bird for the ARCS Precision Medicine Summit (and Community of Practice) closes today!

What’s in Store for Associations in 2021

Building the Future of the DolorClast Method

1° Prolotherapy Master Class

Anti-adhesion agents and evidence based medicine

John Nelson MD,FACC,FNLA,FASNC的更多文章

Real-World Characteristics of US Patients Taking Icosapent Ethyl-Suggests We Need To Do Better and Bridge this Gap in Reducing Residual CV Risk !!!

This is Why in High Risk/Very High Risk Patients-EVEN with an LDL-C<55mg/dl with Triglycerides>/= 150mg/dl -You are NOT DONE REDUCING CVD RISK !!!

Comparison of Product Label vs Real-World Safety Data from Branded Icosapent Ethyl Users:ASelect Analysis Utilizing Market Scan Data

Atherogenic index of plasma and coronary artery disease:a systemic review and meta-analysis of observational studies

First Systemic Review To Evaluate the Effect of EPA in Recent ACS Patients !!!

"Eicosapentaenoic Acid Induces Anti-inflammatory transcriptomic landscape in T cells implicating a Pathway Independent of Triglyceride Lowering in ..

Congratulations to Dr. Richard Oravec for starting the Sports Medicine Residency Program-St.Agnes Medical Center Fresno, California

When looking at published CVOT's only Prescription Icosapent Ethyl added to Statin Therapy has been shown to Reduce Cardiovascular Mortality

Undertreatment of Elevated Triglycerides(Tg) in Patients with CVD-Saw a Patient this week with CAD/Carotid disease with LDL-C 44mg/dl and Tg 230mg/dl

I will be giving a Triglyceride Lecture at the 2024 Heart and Lung Institute Symposium on Saturday February 10th ,2024

社区洞察

其他会员也浏览了

Interview with CTP2016 Keynote Speaker, Dr. Greg Koski, CEO of ACRES

ITM Antwerp Annual Report 2017

CIOMS released today a "Glossary of ICH terms and definitions"

Dr. Paul Davis selected as Top Endocrine Pharmacologist of the Year by the International Association of Top Professionals (IAOTP)

Early bird for the ARCS Precision Medicine Summit (and Community of Practice) closes today!

What’s in Store for Associations in 2021

Building the Future of the DolorClast Method

1° Prolotherapy Master Class

Anti-adhesion agents and evidence based medicine